EUVIMEDEUVIMED entdecken
Crossref

Approach to the Young Male Patient Who Abuses Androgens: Harm Reduction as a Clinical Strategy

Diederik L Smit iD, Tijs Verdegaal iD, Peter Bond iD, Willem de Ronde iD

The Journal of Clinical Endocrinology & Metabolism · 18.12.2025 · 111 (1) · e292-e297

DOI: 10.1210/clinem/dgaf496 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 05.09.2025. Verfasst von Diederik L Smit und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Zaandam Medical Centre, 1502 DV Zaandam, The Netherlands. Hauptthemen laut MEDLINE: Androgens, Harm Reduction, Substance-Related Disorders. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nonmedical use of androgens is increasingly encountered in clinical practice, particularly among young men engaging in strength training. Many present with androgen-related complaints or complications but receive limited medical support because of clinician unfamiliarity, stigma, or the perceived need for abstinence as a condition for care. This article outlines a framework for engaging with androgen abusers in clinical practice, emphasizing a nonjudgmental diagnostic approach and 2 parallel management strategies. For individuals motivated to discontinue, structured monitoring and psychological support are key to facilitating hormonal recovery and reducing relapse risk. Only in cases where biochemical hypogonadism with symptoms persists after at least 12 months of abstinence should testosterone replacement therapy be considered in line with standard guidelines. For those unwilling or not yet ready to stop, a harm reduction approach is proposed. Drawing on extensive clinical experience, we provide recommendations for minimizing health risks, including dose reduction, compound selection, cycle structuring, and cardiovascular risk management. This dual strategy—supporting cessation where possible while mitigating harm where possible—offers a realistic and ethical response to the growing population of androgen abusers and aims to bridge the current gap between clinical care and user behavior.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AndrogensHarm ReductionSubstance-Related DisordersAdultHumansMaleYoung AdultHormone Replacement TherapyHypogonadismTestosterone

Stichwörter der Autor:innen

anabolic steroidsandrogen abusebodybuildingharm reductionhypogonadismtestosterone replacement therapy

Substanzen

AndrogensTestosterone

Autor:innen und Institutionen

  • Department of Internal Medicine, Zaandam Medical Centre, 1502 DV Zaandam, The Netherlands.
  • Department of Performance and Image-Enhancing Drugs Research, Android Health Clinic, 3454 PZ Utrecht, The Netherlands.
  • Department of Internal Medicine, Spaarne Gasthuis, 2035 RC Haarlem, The Netherlands.

ORCID-Profile: Diederik L Smit, Tijs Verdegaal, Peter Bond, Willem de Ronde

Zitieren

APA

Smit, D. L., Verdegaal, T., Bond, P., & de Ronde, W. (2025). Approach to the Young Male Patient Who Abuses Androgens: Harm Reduction as a Clinical Strategy. The Journal of Clinical Endocrinology & Metabolism, 111(1), e292-e297. https://doi.org/10.1210/clinem/dgaf496

Vancouver

Smit DL, Verdegaal T, Bond P, de Ronde W. Approach to the Young Male Patient Who Abuses Androgens: Harm Reduction as a Clinical Strategy. The Journal of Clinical Endocrinology & Metabolism. 2025;111(1):e292-e297. doi:10.1210/clinem/dgaf496

BibTeX
@article{Smit2025,
  author = {Smit, Diederik L and Verdegaal, Tijs and Bond, Peter and de Ronde, Willem},
  title = {Approach to the Young Male Patient Who Abuses Androgens: Harm Reduction as a Clinical Strategy},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {111},
  number = {1},
  pages = {e292--e297},
  doi = {10.1210/clinem/dgaf496}
}
Kostenlos starten →